Resurrecting the Woolly Mammoth

The idea of bringing the woolly mammoth back from extinction has moved from science fiction to a tangible scientific timeline. Colossal Biosciences, a company co-founded by geneticist George Church and entrepreneur Ben Lamm, is actively using CRISPR gene-editing technology to engineer an animal that functions exactly like the ancient mammoth. With significant funding and recent biological breakthroughs, the first calves could be born before the end of the decade.

The Science: Building a Mammoth-Elephant Hybrid

Colossal Biosciences is not strictly “cloning” a mammoth in the way Dolly the sheep was cloned. Because the woolly mammoth has been extinct for 4,000 years, no viable living cells exist to clone. Instead, scientists are engaged in a process of genetic engineering to create a functional hybrid.

The roadmap relies on the Asian elephant. This modern species shares approximately 99.6% of its DNA with the woolly mammoth. Researchers are taking skin cells from Asian elephants and using CRISPR-Cas9 technology to splice in specific mammoth genes recovered from well-preserved fossils found in the Siberian permafrost.

Key Genetic Modifications

To survive in the Arctic, the new animal needs specific traits that modern elephants lack. The team is focusing on editing roughly 50 to 100 specific genes responsible for:

• Thick shaggy hair: To provide insulation against sub-zero temperatures.
• Subcutaneous fat layers: Mammoths require significantly more body fat than elephants to store energy and retain heat.
• Smaller ears: Large ears dissipate heat. The new animal will need small ears to prevent frostbite and conserve warmth.
• Cold-adapted hemoglobin: This allows blood to deliver oxygen efficiently even at extreme low temperatures.

A Major Breakthrough: The iPSC Achievement

In March 2024, Colossal Biosciences announced a massive step forward that makes this de-extinction possible. For the first time, their team successfully derived induced pluripotent stem cells (iPSCs) from Asian elephant cells.

This was a scientific hurdle that had stumped researchers for years. Elephant cells contain a complex pathway called TP53, which suppresses tumors but also makes cells resistant to reprogramming. By overcoming this, the team can now grow any type of elephant tissue in the lab—including hair, blood, and fat—to test their gene edits without needing live animals for early experiments. This milestone significantly de-risks the timeline for the project.

The Ecological Goal: Restoring the Mammoth Steppe

The motivation behind this project extends beyond curiosity. The stated goal is ecological restoration. During the Pleistocene era, the Arctic was a grassland known as the Mammoth Steppe. Today, it is largely mossy tundra and taiga forest that is less efficient at keeping the ground frozen.

Colossal argues that reintroducing large herds of cold-resistant grazers will restore the grasslands. The theory involves three mechanisms:

1. Snow Compaction: Heavy animals trample thick snow layers. This removes the insulating snow cover, allowing extreme cold air to penetrate the ground and keep the permafrost frozen.
2. Albedo Effect: Grasslands reflect more solar radiation than dark forests, helping cool the region.
3. Carbon Sequestration: By preventing permafrost thaw, the project aims to stop the release of trapped greenhouse gases, specifically methane and carbon dioxide.

Timeline and The Birth Process

Ben Lamm, the CEO of Colossal, has publicly stated a target date of 2028 for the birth of the first mammoth calves. However, biology dictates a slow pace.

Once a functional embryo is created, it must be brought to term. The gestation period for an elephant is approximately 22 months, the longest of any land mammal. This creates a logistical bottleneck.

The Surrogate Challenge

The team faces a choice regarding how to birth the animal:

• Surrogate Mothers: Using an Asian elephant as a surrogate is the most immediate option. However, Asian elephants are endangered. Implanting a hybrid embryo that might be larger or biologically different poses ethical and physical risks to the mother.
• Artificial Wombs: Colossal is heavily investing in ex-vivo (outside the body) gestation technology. Developing an artificial womb would allow them to scale the population of mammoths without burdening the existing Asian elephant population. This technology is currently in development but has not yet been perfected for large mammals.

Funding and Future Projects

The project has attracted massive capital. Colossal Biosciences has raised over $225 million in total funding, with investors ranging from the CIA’s venture capital firm In-Q-Tel to private equity firms.

While the mammoth is the flagship project, the technology developed here applies to other de-extinction efforts. Colossal has launched concurrent programs to resurrect the Thylacine (Tasmanian Tiger), which went extinct in 1936, and the Dodo bird. The breakthrough with elephant stem cells provides a blueprint that accelerates these other projects as well.

Frequently Asked Questions

Will the new animal be 100% Woolly Mammoth? No. It will be a cold-resistant elephant with mammoth traits. Colossal refers to it as a “Arctic Elephant” or a functional mammoth. Genetically, it will be mostly Asian elephant with key mammoth phenotypes.

When will the first mammoth be born? Colossal Biosciences is targeting 2028 for the birth of the first calves. Given the 22-month gestation period, successful embryo implantation would need to occur by 2025 or 2026.

Where will the mammoths live? The long-term plan is to release them into the Arctic regions of Alaska or Siberia. Organizations like Pleistocene Park in Russia are already preparing land for the reintroduction of large grazers, though political complexities may shift the initial release locations to North America.

Is this similar to Jurassic Park? Not exactly. Jurassic Park relied on retrieving liquid blood from mosquitoes trapped in amber, which is biologically impossible because DNA degrades over millions of years. This project uses existing, compatible DNA from a living relative (the elephant) and edits it using verified genetic data from fossils that are only thousands of years old.